Thus, glycation exhibits significant implications in promoting cancers, and, on the contrary, deglycation of certain proteins such as Nrf2, particularly in preventing cancers, may deliver effective clinical outcomes, which must be tested in clinical settings. The gene discussed is NFE2L2; the disease is cancer.